U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Manning Paul B (0001494695)
Mailing Address
200 GARRETT STREET SUITE S
CHARLOTTESVILLE VA 22902
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Pasithea Therapeutics Corp. 0001841330 2022-10-22 10 percent owner
Candel Therapeutics, Inc. 0001841387 2021-07-26 director
Acumen Pharmaceuticals, Inc. 0001576885 2021-06-30 10 percent owner
Liquidia Corp 0001819576 2020-11-18 director, 10 percent owner
Taysha Gene Therapies, Inc. 0001806310 2020-09-23 director, 10 percent owner
Verrica Pharmaceuticals Inc. 0001660334 2018-06-14 director, 10 percent owner
Dova Pharmaceuticals Inc. 0001685071 2017-06-28 director, 10 percent owner
AveXis, Inc. 0001652923 2016-02-10 director, 10 percent owner
PERRIGO CO 0000820096 2010-06-09 officer: EVP & General Manager, PBM


Items 1 - 80

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-12-16   Candel Therapeutics, Inc. 4 P-Purchase --I 750000.0000 1303752.0000 2 0001841387 Common Stock
A 2024-12-16   Candel Therapeutics, Inc. 4 P-Purchase --I 500000.0000 1142406.0000 1 0001841387 Common Stock
D 2024-11-26   Verrica Pharmaceuticals Inc. 4 G-Gift --D 450000.0000 25828094.0000 3 0001660334 Common Stock
A 2024-11-22   Verrica Pharmaceuticals Inc. 4 P-Purchase --I 2247191.0000 2247191.0000 12 0001660334 Series B Warrants (right to buy)
A 2024-11-22   Verrica Pharmaceuticals Inc. 4 P-Purchase --I 2247191.0000 2247191.0000 11 0001660334 Series A Warrants (right to buy)
A 2024-11-22   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 9213483.0000 9213483.0000 10 0001660334 Series B Warrants (right to buy)
A 2024-11-22   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 9213483.0000 9213483.0000 9 0001660334 Series A Warrants (right to buy)
A 2024-11-22   Verrica Pharmaceuticals Inc. 4 P-Purchase --I 4494382.0000 5976101.0000 2 0001660334 Common Stock
A 2024-11-22   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 18426966.0000 26278094.0000 1 0001660334 Common Stock
D 2024-09-19   Verrica Pharmaceuticals Inc. 4 G-Gift --I 2675611.2500 0.0000 1 0001660334 Common Stock
A 2024-09-19   Verrica Pharmaceuticals Inc. 4 G-Gift --I 891870.4100 891870.4100 2 0001660334 Common Stock
A 2024-09-19   Verrica Pharmaceuticals Inc. 4 G-Gift --I 891870.4200 891870.4200 3 0001660334 Common Stock
A 2024-09-19   Verrica Pharmaceuticals Inc. 4 G-Gift --I 891870.4200 891870.4200 4 0001660334 Common Stock
A 2024-09-12   Liquidia Corp 4 P-Purchase --I 337078.0000 816311.0000 1 0001819576 Common Stock
A 2024-06-27   Taysha Gene Therapies, Inc. 4 P-Purchase --D 1333333.0000 1333333.0000 1 0001806310 Common Stock
A 2024-06-26   Candel Therapeutics, Inc. 4 A-Award --D 14240.0000 14240.0000 1 0001841387 Stock Option (Right to Buy)
A 2024-06-20   Liquidia Corp 4 A-Award --D 20359.0000 299689.0000 1 0001819576 Common Stock
A 2023-12-14   Liquidia Corp 4 P-Purchase --D 279330.0000 279330.0000 1 0001819576 Common Stock
A 2023-11-17   Taysha Gene Therapies, Inc. 4 P-Purchase --I 100000.0000 16566667.0000 1 0001806310 Common Stock
A 2023-08-16   Taysha Gene Therapies, Inc. 4 P-Purchase --I 16466667.0000 16466667.0000 1 0001806310 Common Stock
A 2023-07-24   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 200000.0000 7851128.0000 1 0001660334 Common Stock
A 2023-06-28   Candel Therapeutics, Inc. 4 A-Award --D 14240.0000 14240.0000 1 0001841387 Stock Option (Right to Buy)
A 2023-06-19   Liquidia Corp 4 A-Award --D 20000.0000 20000.0000 1 0001819576 Non-Qualified Stock Option (right to buy)
A 2022-10-31   Taysha Gene Therapies, Inc. 4 P-Purchase --D 1500000.0000 1642202.0000 1 0001806310 Common Stock
A 2022-10-13   Candel Therapeutics, Inc. 4 A-Award --D 14240.0000 14240.0000 1 0001841387 Stock Option (Right to Buy)
A 2022-07-05   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 4761904.0000 13651128.0000 1 0001660334 Common Stock
A 2022-06-17   Liquidia Corp 4 A-Award --D 20000.0000 20000.0000 1 0001819576 Non-Qualified Stock Option (right to buy)
A 2022-06-17   Taysha Gene Therapies, Inc. 4 A-Award --D 15500.0000 15500.0000 1 0001806310 Stock Option (right to buy)
A 2022-04-18   Liquidia Corp 4 P-Purchase --D 392156.0000 392156.0000 1 0001819576 Common Stock
A 2022-03-31   Liquidia Corp 4 A-Award --I 435674.0000 435674.0000 1 0001819576 Common Stock
A 2022-02-03   Taysha Gene Therapies, Inc. 4 P-Purchase --D 50000.0000 142202.0000 4 0001806310 Common Stock
A 2022-02-03   Taysha Gene Therapies, Inc. 4 P-Purchase --I 26602.0000 2091704.0000 5 0001806310 Common Stock
A 2022-02-02   Taysha Gene Therapies, Inc. 4 P-Purchase --D 58000.0000 92202.0000 1 0001806310 Common Stock
A 2022-02-02   Taysha Gene Therapies, Inc. 4 P-Purchase --I 45000.0000 2065102.0000 2 0001806310 Common Stock
A 2022-02-02   Taysha Gene Therapies, Inc. 4 P-Purchase --I 22000.0000 22000.0000 3 0001806310 Common Stock
A 2021-12-03   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 19977.0000 8149394.0000 2 0001660334 Common Stock
A 2021-12-02   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 30023.0000 8129417.0000 1 0001660334 Common Stock
A 2021-11-24   Taysha Gene Therapies, Inc. 4 P-Purchase --D 2202.0000 34202.0000 1 0001806310 Common Stock
A 2021-11-23   Taysha Gene Therapies, Inc. 4 P-Purchase --D 20000.0000 32000.0000 1 0001806310 Common Stock
A 2021-09-07   Liquidia Corp 5 G-Gift --D 4460308.0000 4460308.0000 4 0001819576 Common Stock
D 2021-09-07   Liquidia Corp 5 G-Gift --I 4460308.0000 198413.0000 3 0001819576 Common Stock
A 2021-08-20   Liquidia Corp 4 A-Award --D 20000.0000 20000.0000 1 0001819576 Non-Qualified Stock Option (right to buy)
A 2021-07-29   Candel Therapeutics, Inc. 4 P-Purchase --D 20000.0000 56000.0000 2 0001841387 Common Stock
A 2021-07-29   Candel Therapeutics, Inc. 4 C-Conversion --I 679158.0000 679158.0000 1 0001841387 Common Stock
A 2021-07-29   Candel Therapeutics, Inc. 4 C-Conversion --I 553752.0000 553752.0000 2 0001841387 Common Stock
D 2021-07-29   Candel Therapeutics, Inc. 4 C-Conversion --I 1669303.0000 0.0000 4 0001841387 Series B Preferred Stock
D 2021-07-29   Candel Therapeutics, Inc. 4 C-Conversion --I 1361069.0000 0.0000 5 0001841387 Series B Preferred Stock
A 2021-07-29   Candel Therapeutics, Inc. 4/A C-Conversion --I 679158.0000 679158.0000 1 0001841387 Common Stock
A 2021-07-29   Candel Therapeutics, Inc. 4/A C-Conversion --I 553752.0000 553752.0000 2 0001841387 Common Stock
A 2021-07-29   Candel Therapeutics, Inc. 4/A P-Purchase --D 1625000.0000 1681000.0000 3 0001841387 Common Stock
D 2021-07-29   Candel Therapeutics, Inc. 4/A C-Conversion --I 1669303.0000 0.0000 4 0001841387 Series B Preferred Stock
D 2021-07-29   Candel Therapeutics, Inc. 4/A C-Conversion --I 1361069.0000 0.0000 5 0001841387 Series B Preferred Stock
A 2021-07-27   Candel Therapeutics, Inc. 4 P-Purchase --D 36000.0000 36000.0000 1 0001841387 Common Stock
D 2021-07-14   Candel Therapeutics, Inc. 5 G-Gift --I 36752.0000 642406.0000 1 0001841387 Common Stock
D 2021-07-06   Acumen Pharmaceuticals, Inc. 4 C-Conversion --I 657985.0000 0.0000 6 0001576885 Series B Preferred Stock
D 2021-07-06   Acumen Pharmaceuticals, Inc. 4 C-Conversion --I 1315969.0000 0.0000 5 0001576885 Series B Preferred Stock
D 2021-07-06   Acumen Pharmaceuticals, Inc. 4 C-Conversion --I 1634515.0000 0.0000 4 0001576885 Series A-1 Preferred Stock
A 2021-07-06   Acumen Pharmaceuticals, Inc. 4 C-Conversion --I 657985.0000 657985.0000 3 0001576885 Common Stock
A 2021-07-06   Acumen Pharmaceuticals, Inc. 4 P-Purchase --I 312500.0000 3352693.0000 2 0001576885 Common Stock
A 2021-07-06   Acumen Pharmaceuticals, Inc. 4 C-Conversion --I 2950484.0000 3040193.0000 1 0001576885 Common Stock
D 2021-07-06   Verrica Pharmaceuticals Inc. 5 G-Gift --I 739830.0000 0.0000 1 0001660334 Common Stock
A 2021-07-06   Verrica Pharmaceuticals Inc. 5 G-Gift --D 739830.0000 8889224.0000 2 0001660334 Common Stock
A 2021-07-06   Liquidia Corp 5 G-Gift --I 3921075.0000 4658721.0000 2 0001819576 Common Stock
D 2021-07-06   Liquidia Corp 5 G-Gift --I 3921075.0000 0.0000 1 0001819576 Common Stock
A 2021-06-17   Taysha Gene Therapies, Inc. 4 A-Award --D 15500.0000 15500.0000 1 0001806310 Stock Option (right to buy)
A 2021-05-14   Taysha Gene Therapies, Inc. 4 P-Purchase --D 12000.0000 12000.0000 1 0001806310 Common Stock
A 2021-04-13   Liquidia Corp 4 P-Purchase --I 198413.0000 737646.0000 1 0001819576 Common Stock
A 2021-03-25   Verrica Pharmaceuticals Inc. 4 P-Purchase --I 739830.0000 739830.0000 1 0001660334 Common Stock
A 2021-03-24   Liquidia Corp 4 A-Award --D 21385.0000 21385.0000 1 0001819576 Non-Qualified Stock Option (right to buy)
D 2020-12-31   Taysha Gene Therapies, Inc. 5 G-Gift --I 80000.0000 3195205.0000 1 0001806310 Common Stock
A 2020-11-18   Liquidia Corp 4 A-Award --D 30000.0000 30000.0000 1 0001819576 Non-Qualified Stock Option (right to buy)
A 2020-09-28   Taysha Gene Therapies, Inc. 4 C-Conversion --I 3275205.0000 3275205.0000 1 0001806310 Common Stock
A 2020-09-28   Taysha Gene Therapies, Inc. 4 C-Conversion --I 2008158.0000 2008158.0000 2 0001806310 Common Stock
A 2020-09-28   Taysha Gene Therapies, Inc. 4 C-Conversion --I 11944.0000 2020102.0000 3 0001806310 Common Stock
D 2020-09-28   Taysha Gene Therapies, Inc. 4 C-Conversion --I 3006155.0000 0.0000 4 0001806310 Series A Preferred Stock
D 2020-09-28   Taysha Gene Therapies, Inc. 4 C-Conversion --I 10963.0000 0.0000 6 0001806310 Series B Preferred Stock
D 2020-09-28   Taysha Gene Therapies, Inc. 4 C-Conversion --I 1843193.0000 0.0000 5 0001806310 Series A Preferred Stock
A 2020-09-23   Taysha Gene Therapies, Inc. 4 A-Award --D 31000.0000 31000.0000 1 0001806310 Stock Option (right to buy)
A 2020-08-20   Verrica Pharmaceuticals Inc. 4 P-Purchase --D 20000.0000 8099394.0000 1 0001660334 Common Stock
A 2020-08-18   Verrica Pharmaceuticals Inc. 4 P-Purchase --I 10000.0000 1481719.0000 1 0001660334 Common Stock

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016